Respiratory syncytial virus, or RSV, is a common virus that spreads through respiratory droplets β the tiny particles people release when they cough, sneeze, or talk. Most people think of RSV as something that affects babies and young children, which is true. But RSV also causes serious illness in older adults, particularly those age 60 and above. The virus infects the lungs and airways, leading to symptoms like coughing, congestion, wheezing, and difficulty breathing.
Learn About Paying Your FGUA Bill Online β
For seniors, RSV infection can lead to pneumonia, bronchitis, or other complications that require hospitalization. According to the Centers for Disease Control and Prevention, each year approximately 160,000 older adults are hospitalized due to RSV, and around 6,000 to 10,000 older adults die from RSV-related illness annually in the United States. These numbers rival or exceed hospitalization rates for influenza in seniors. Despite this, many older adults have never heard of RSV or don't realize how serious it can be for their age group.
The disease typically spreads during fall and winter months, similar to the flu, though RSV can occur year-round in some regions. Seniors in congregate settings β such as assisted living facilities, nursing homes, or community centers where many people gather β face higher risk of exposure. People with chronic heart disease, chronic lung disease, weakened immune systems, or other underlying health conditions may experience more severe RSV illness.
Understanding what RSV is represents the foundation for making informed decisions about your health. Our free information guide walks through the basics: how RSV spreads, what symptoms to watch for, which groups face higher risk, and how the disease progresses. Knowing this background helps you recognize when RSV might be present and understand why health organizations have developed new tools to protect older adults.
Takeaway: RSV is a serious respiratory virus that sends thousands of seniors to hospitals each year. Learning about RSVβits symptoms, transmission, and risksβis the first step toward understanding protection options available to you.
For decades, there was no vaccine for RSV. Older approaches to RSV prevention focused on hand hygiene, avoiding crowds during peak seasons, and managing symptoms once infection occurred. This changed in 2023 when the FDA approved the first RSV vaccines specifically for adults age 60 and older. These vaccines represent a significant shift in how seniors can protect themselves against this virus.
Free Guide to Pay by Plate Illinois Billing β
Two RSV vaccines became available for seniors: Arexvy (made by GlaxoSmithKline) and Abrysvo (made by Pfizer). Both vaccines use recombinant technology, meaning they contain a protein piece from RSV rather than the whole virus or a weakened form. This approach reduces the risk of vaccine side effects while still teaching the immune system to recognize and fight RSV. The vaccines differ slightly in their composition and how they're administered, but both underwent rigorous clinical trials before approval.
Clinical trial data showed that these vaccines reduced the risk of severe RSV illness by approximately 70-80% in older adults. In practical terms, this means vaccinated seniors who do contract RSV experience milder illness with lower rates of hospitalization compared to unvaccinated seniors. The vaccines do not prevent all RSV infections β breakthrough infections can still occur β but they significantly reduce the chances of serious complications.
The CDC's Advisory Committee on Immunization Practices (ACIP) reviewed the evidence and issued recommendations about RSV vaccination for seniors. Their guidance emphasizes that these vaccines are particularly valuable for adults age 75 and older, and for adults age 60-74 who have chronic heart disease, chronic lung disease, or weakened immune systems. However, shared clinical decision-making is recommended for some groups, meaning you and your healthcare provider discuss whether vaccination makes sense for your individual situation.
Our guide explains how each vaccine works at a basic level, what clinical trials showed, and what the official recommendations say about who might benefit most from vaccination. This information helps you have a more informed conversation with your doctor about whether an RSV vaccine might be right for you.
Takeaway: New RSV vaccines for seniors became available in 2023 and reduced severe illness risk by 70-80% in clinical trials. Understanding how these vaccines work and what evidence supports them helps you discuss options with your healthcare provider.
Once you decide you want to learn more about RSV vaccines, several official sources provide reliable information. The Centers for Disease Control and Prevention maintains comprehensive pages about RSV vaccines, including how they work, who should consider them, and what to expect. The CDC website includes fact sheets that you can read at your own pace or print out to share with your doctor. The FDA's website contains approved vaccine information and prescribing details for healthcare providers.
Free Guide to Mold Removal Methods for Walls β
Your healthcare provider β whether that's your primary care doctor, a nurse practitioner, or a physician assistant β represents another crucial information source. These professionals know your medical history, current medications, and any previous vaccine reactions. They can explain how RSV vaccination fits into your overall preventive care plan and answer questions specific to your health situation. If you haven't seen a healthcare provider recently, scheduling a visit gives you the chance to discuss RSV vaccination along with other preventive measures.
State health departments also publish RSV information and vaccination resources. Calling your state health department's hotline or visiting their website shows you where RSV vaccines are available in your area and what you should know before visiting a vaccination site. Many state health departments also provide information in multiple languages and formats for people with different needs.
Our free guide compiles key information from these official sources into one document organized by topic. Rather than jumping between multiple websites, the guide presents information about RSV itself, vaccine details, recommendations from major health organizations, and questions you might ask your doctor β all in one place. The guide is organized to be straightforward to navigate, with sections you can read in any order depending on what matters most to you.
When reviewing any health information, look for sources that cite their data and explain where information comes from. Be cautious of sources making dramatic promises or creating urgency to make decisions quickly. Good health information is clear about what is known, what remains uncertain, and where to find more details.
Takeaway: Multiple reliable sources provide RSV vaccine information, including the CDC, FDA, your healthcare provider, and state health departments. Our guide brings together the most relevant information from these sources in an organized format.
Before deciding whether to discuss RSV vaccination with your doctor, it's worth reflecting on your own health situation. Everyone's risk from RSV differs based on age, underlying health conditions, living situation, and exposure opportunities. The more you understand your own risk profile, the better prepared you'll be to have a conversation with your healthcare provider about whether vaccination makes sense for you.
How to Delete Your Fitbit Account Guide β
Age alone influences RSV risk. Adults age 75 and older face the highest risk of severe RSV illness. However, adults age 60-74 with certain chronic conditions also experience significant risk. Chronic conditions that matter for RSV risk include chronic obstructive pulmonary disease (COPD), asthma, emphysema, chronic bronchitis, heart disease, congestive heart failure, and diabetes. If you have any of these conditions, your risk from RSV is higher than it would be if you were otherwise healthy.
Your immune system status also influences how seriously RSV affects you. Seniors who are on immunosuppressive medications β either for autoimmune conditions or because they've had an organ transplant β experience more severe RSV illness if infected. Similarly, people being treated for cancer, people with HIV, and people with other conditions affecting immune function should understand that RSV poses particular risks for them.
Your living situation and social connections matter, too. If you live in a congregate setting such as an assisted living facility or nursing home, you face higher exposure to RSV. Similarly, if you spend significant time around young children who attend school or daycare, you have more opportunity to encounter RSV. These exposure patterns don't necessarily mean you need vaccination, but they're relevant information for discussing your situation with your healthcare provider.
Our guide includes a section prompting you to think through these aspects of your health history. It suggests writing down your chronic conditions, your living situation, your immune status, and any previous serious respiratory illnesses. Having this information organized before you speak with your doctor makes the conversation more efficient and ensures you provide the information your
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.